Human papillomavirus vaccine - Biogen Idec
Alternative Names: Cervical cancer vaccine - Biogen Idec; Cervical dysplasia vaccine - Biogen Idec; E7 protein vaccine; HPV 16 vaccineLatest Information Update: 24 Oct 2021
At a glance
- Originator Biogen Idec
- Class Cancer vaccines; Papillomavirus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Human papillomavirus infections
Most Recent Events
- 17 Nov 2003 IDEC Pharmaceuticals has merged with Biogen to form Biogen Idec
- 20 Jun 2002 Phase-I clinical trials in Human papillomavirus infections in USA (unspecified route)
- 11 Jun 1999 Preclinical development for Human papillomavirus infections in USA (Unknown route)